11 reports of this reaction
2.0% of all EPHEDRINE SULFATE reports
#8 most reported adverse reaction
RESPIRATORY ARREST is the #8 most commonly reported adverse reaction for EPHEDRINE SULFATE, manufactured by Foundation Consumer Healthcare LLC. There are 11 FDA adverse event reports linking EPHEDRINE SULFATE to RESPIRATORY ARREST. This represents approximately 2.0% of all 545 adverse event reports for this drug.
Patients taking EPHEDRINE SULFATE who experience respiratory arrest should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RESPIRATORY ARREST is a less commonly reported adverse event for EPHEDRINE SULFATE, but still significant enough to appear in the safety profile.
In addition to respiratory arrest, the following adverse reactions have been reported for EPHEDRINE SULFATE:
The following drugs have also been linked to respiratory arrest in FDA adverse event reports:
RESPIRATORY ARREST has been reported as an adverse event in 11 FDA reports for EPHEDRINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RESPIRATORY ARREST accounts for approximately 2.0% of all adverse event reports for EPHEDRINE SULFATE, making it a notable side effect.
If you experience respiratory arrest while taking EPHEDRINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.